文献速递胃肠外科

经肛与腹腔镜全直肠系膜切除术治疗直肠癌的配对队列研究荟萃分析

Outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis and trial sequential analysis of matched cohort studies.
PubMed 文献 · Surg Endosc · 2025-08-28

该研究纳入32篇配对队列研究共6970例患者,比较经肛全直肠系膜切除术(taTME)与腹腔镜全直肠系膜切除术(laTME)的围手术期和肿瘤学结果。taTME组中转开腹率、环周切缘(CRM)阳性率和远端切缘(DRM)阳性率显著更低,其他结局无差异;CRM阳性率和中转开腹的累积Z曲线超过传统边界和试验序贯监测边界,证据较强,但DRM阳性率可能存在假阳性。

要点

  • taTME组中转开腹率显著低于laTME组(OR=0.14,95%CI 0.09-0.22,P<0.01)。
  • taTME组CRM阳性率显著更低(OR=0.64,95%CI 0.49-0.85,P<0.01),证据强度较高。
  • taTME组DRM阳性率显著更低(OR=0.57,95%CI 0.36-0.89,P=0.01),但试验序贯分析提示可能为假阳性。

核心结论

  • 基于配对队列研究的荟萃分析显示,taTME可能在CRM阳性率和中转开腹率方面具有优势,其他结局与laTME相当。
  • taTME在DRM阳性率方面是否获益尚需进一步研究。

研究设计与样本

  • 荟萃分析和试验序贯分析,纳入32篇配对队列研究,共6970例患者。
  • 检索Cochrane Library、Web of Science、Embase和PubMed数据库至2025年1月20日。
  • 采用纽卡斯尔-渥太华量表进行质量评价,采用GRADE系统评估证据总体确定性。

主要发现

  • taTME组与laTME组相比,中转开腹率(OR=0.14,95%CI 0.09-0.22,P<0.01)、CRM阳性率(OR=0.64,95%CI 0.49-0.85,P<0.01)和DRM阳性率(OR=0.57,95%CI 0.36-0.89,P=0.01)均显著更低。
  • 其他围手术期问题和肿瘤学结局无差异。
  • CRM阳性率和中转开腹的累积Z曲线超过传统边界和试验序贯监测边界,提示证据强;DRM阳性率显示可能的假阳性。
  • 与较差的CRM和DRM阳性率相比,中转开腹的推荐等级为中等。

关键数值与推荐

  • GRADE证据分级:CRM阳性率和DRM阳性率推荐等级较差,中转开腹推荐等级为中等。
  • 试验序贯分析:CRM阳性率和中转开腹的累积Z曲线超过传统边界和试验序贯监测边界,证据强;DRM阳性率可能为假阳性。

临床怎么用

  • taTME可能降低中转开腹率和CRM阳性率,可作为直肠癌手术的选项之一。
  • 对于DRM阳性率的获益需谨慎解读,尚需更多研究确认。

局限性

  • 缺乏足够的高质量随机对照试验,结果基于配对队列研究。
  • DRM阳性率的获益可能存在假阳性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The perioperative and oncological results of laparoscopic total mesorectal excision (laTME) and transanal total mesorectal excision (taTME) have been compared. However, because there are not enough high-quality randomized controlled trials (RCTs), the results cannot be trusted. In order to get more trustworthy results, this article analyzed matched cohort studies. METHODS: Until January 20, 2025, extensive searches were conducted across the Cochrane Library, Web of Science, Embase, and PubMed databases. Using meta-analysis and trial sequential analysis (TSA), we assessed the oncological and perioperative results. Quality assessment was done using the Newcastle-Ottawa Scale. To gauge the overall level of certainty in the evidence, we employed the Grading of Recommendations Assessment, Development, and Evaluation system (GRADE). RESULTS: 6970 patients from 32 papers were included in the analysis. Comparing the taTME group to the laTME group, the open conversion rate (OR = 0.14, 95% CI = 0.09 to 0.22, P < 0.01), circumferential resection margin (CRM) positivity rate (OR = 0.64, 95% CI = 0.49 to 0.85, P < 0.01), and distal resection margin (DRM) positivity rate (OR = 0.57; 95% CI = 0.36 to 0.89; P = 0.01) were significantly lower. Other perioperative problems and oncological outcomes did not differ. The cumulative Z-curve for CRM positivity rate and open conversion both exceeded the conventional boundary and the trial sequential monitoring border, suggesting strong evidence; however, the DRM positivity rate showed possible false positives. In contrast to the poor CRM and DRM-positive rates, the recommendations for open conversion had a moderate grade. CONCLUSION: Based on matched cohort studies, this meta-analysis shows that taTME may offer advantages in CRM positivity and open conversion rate but shows comparable results for other outcomes. To ascertain whether taTME offers benefits in terms of DRM positively, more investigation is required.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zhao L, Li L, Xiao D, et al. Outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis and trial sequential analysis of matched cohort studies. Surg Endosc. 2025. PMID: 40877625. doi:10.1007/s00464-025-12121-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。